VGXI: News

Stephanie Burke Named as VGXI’s New Chief Accounting Officer

Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Stephanie Burke as its new[…]

  Read More

VGXI, Inc. Names Jeff Whitmore as New Chief Commercial Officer

Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Jeff Whitmore as its new Chief[…]

  Read More

VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility

With original operations based in The Woodlands, TX, industry recognized plasmid DNA contract[…]

  Read More

VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility

Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening[…]

  Read More

VGXI Celebrates First Look Event at New Manufacturing Facility

VGXI opened the doors of its new headquarters and manufacturing facility on 09Apr22 to provide[…]

  Read More

VGXI Official COVID-19 Statement

To our Valued Clients and Business Partners, VGXI’s top priority is to continue delivering[…]

  Read More

VGXI Partner IMM Announces $12M NIH Grant to Support Phase 1 Clinical Trial of a DNA Vaccine for the Prevention of Alzheimer’s Disease

Texas-based CDMO VGXI, Inc. is excited to announce that its partner, The Institute for[…]

  Read More

VGXI New Manufacturing Facility Achieves Construction Milestones In Advance of 2022 Operational Date

Specialized GMP contract manufacturer VGXI, Inc. announced multiple construction milestones[…]

  Read More

VGXI, Inc. Partners with Rare Trait Hope Fund in Support of Gene Therapy for Rare Disease, AGU

Industry leading plasmid DNA Manufacturer VGXI, Inc. partners with Rare Trait Hope Fund in[…]

  Read More